Nikita C Thomas

Nikita C Thomas

Auto-generated profile, based on publicly available information

Nikita C Thomas

Section of General Internal Medicine, Department of Medicine, University of Chicago, 5841 S Maryland Ave, Chicago, IL, 60637, United States, 1 773-702-3608

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2026 in Asian/Pacific Island Nursing Journal
Verified
Journal Article
Open access
JXJason Xiao
Jason Xiao
JYJielu Yu
Jielu Yu
ESErin Staab
Erin Staab
NTNikita C Thomas
Nikita C Thomas
WWWen Wan
Wen Wan
NLNeda Laiteerapong
Neda Laiteerapong
Background: Asian American and Pacific Islander populations are disproportionately affected by diabetes. Objective: The purpose of this study was to assess the efficacy of nonpharmacologic interventions in reducing hemoglobin A 1c (HbA 1c ) levels among Asian American or Pacific Islander individuals with type 2 diabetes. Methods: A systematic review was conducted using the PubMed, Scopus, PsycInfo, and CINAHL databases, covering studies published from 1985 to 2019. Eligible studies were randomized controlled trials that evaluated nonpharmacologic interventions in outpatient settings for adults with type 2 diabetes in the United States, with at least 50% Asian American or Pacific Islander participants. Data extraction and risk of bias assessment were independently performed by 2 reviewers for each trial. The Cochrane Collaboration risk of bias tool and the Grading of Recommendations, Assessment, Development, and Evaluation approach were used to evaluate quality. Random-effects meta-analyses were conducted to estimate pooled effect sizes. Results: A total of 1835 articles were screened, with 9 randomized controlled trials meeting the inclusion criteria, comprising 1492 participants, with a median follow-up duration of 6 (IQR 3-12) months. Interventions included diabetes self-management education, bilingual counseling, glucose or weight monitoring, motivational interviewing, and financial support, often tailored to the cultural context of the participants. Pooled analysis of the 9 trials demonstrated a significant average HbA 1c reduction of −0.39% (95% CI −0.64% to −0.14%; I ²=65%). Seven studies were judged to have a low risk of bias, 1 study had some concerns, and 1 study was assessed as high risk. The overall strength of evidence was high. Conclusions: Nonpharmacologic interventions substantively reduced HbA 1c levels in Asian American or Pacific Islander individuals with type 2 diabetes, particularly when culturally and linguistically tailored.